Table 2.
Summary of data from case reports
| n (N tot = 17) | % | |
|---|---|---|
| Anagraphic data | ||
| Age | 58.6 ± 15.2 | |
| M/F | 12/5 | 70.5%/29.5% |
| Days of COVID symptoms/diagnosis prior to vascular event | 6.1 ± 15.4 | |
| Diagnosed through clinical presentation | 4 | 23.5% |
| COVID+ on admission/first day | 9 | 52.5% |
| COVID+ during hospitalization | 4 | 23.5% |
| Comorbidities | N tot available 16 | |
| Comorbidities present | 11 | 64.7% |
| None | 5 | 29.4% |
| Hypertension | 8 | 47.0% |
| Renal pathology | 3 | 17.6% |
| Previous coronary artery disease | 3 | 17.6% |
| Previous aortic surgery | 2 | 11.7% |
| Arrhythmia | 2 | 11.7% |
| Previous cerebrovascular disease | 1 | 5.8% |
| Diabetes | 1 | 5.8% |
| Autoimmune disease (Crohn disease) | 1 | 5.8% |
| Previous neoplastic condition | 1 | 5.8% |
| BPCO | 1 | 5.8% |
| Heart failure | 1 | 5.8% |
| Clinical presentation | ||
| Fever | 8 | 47.0% |
| Thoracic pain | 8 | 47.0% |
| Respiratory symptoms | 6 | 35.2% |
| Low lymphocyte count | 3 | 17.6% |
| Ruptured aneurysm | 2 | 11.7% |
| Ischemic stroke | 2 | 11.7% |
| Abdominal pain | 2 | 11.7% |
| Acute renal insufficiency | 1 | 5.8% |
| Aortic pathology | ||
| Type A aortic dissection | 11 | 64.7% |
| New pathology of previous aortic graft (1 bilateral branch thrombosis; 1 aneurysm rupture proximal end point) | 2 | 11.7% |
| Aortitis (associated to dissection in 1 case) | 2 | 11.7% |
| thoracoabdominal aortic aneurysm | 1 | 5.8% |
| Abdominal aortic aneurysm with rupture | 1 | 5.8% |
| Embolizing aortic thrombosis | 1 | 5.8% |
| Management | ||
| Open surgery | 10 | 58.8% |
| Endovascular | 3 | 17.6% |
| Exitus before treatment | 3 | 17.6% |
| Conservative | 1 | 5.8% |
| Outcome | ||
| Total mortality | 4 | 23.5% |
| • multi-organ failure 11th day postaortic arch repair for type A dissection | 1 | 5.8% |
| • waiting for surgery previous endo-graft thrombosis | 1 | 5.8% |
| • aortitis and acute aortic dissection after steroidal therapy for COVID | 1 | 5.8% |
| • Acute aortic dissection on aortic root enlargement after 1 week hospitalization for COVID symptoms | 1 | 5.8% |
Anagraphic data, details on coomorbidities, aortic pathology clinical presentation, management and outcome have been analyzed.